Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a value-based oncology care company focused on delivering community-based cancer treatment across the United States. The company entered public markets in 2021 through a special purpose acquisition company merger in the healthcare sector, and this Form 10-Q, filed with the SEC on August 16, 2021, reflects its reporting obligations during that transitional period ahead of the business combination closing. Headquartered in California, The Oncology Institute operates a network of community oncology clinics designed to expand access to evidence-based cancer care for underserved patient populations. To access full filing history, deal timelines, and comprehensive SPAC data on TOI and hundreds of other transactions, sign up for SpacDesk.